Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chitogenx Inc (CHNXF)

Chitogenx Inc (CHNXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,238
  • Shares Outstanding, K 34,960
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,770 K
  • 60-Month Beta -1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CHNXF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $-0.01 on 01/02/24
  • Latest Earnings Date 05/29/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0354 unch
on 05/03/24
0.0500 -29.20%
on 04/19/24
-0.0040 (-10.15%)
since 04/01/24
3-Month
0.0350 +1.14%
on 03/05/24
0.0530 -33.21%
on 02/21/24
-0.0216 (-37.89%)
since 02/02/24
52-Week
0.0350 +1.14%
on 03/05/24
0.1260 -71.90%
on 05/10/23
-0.0936 (-72.56%)
since 05/03/23

Most Recent Stories

More News
CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

/CNW/ - ChitogenX Inc. (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that Philippe...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS

Launch of new skin repair development program targeting $19B in unmet medical needs Successful demonstration of protection from joint degeneration and...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY

/CNW/ - ChitogenX Inc. (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that ORTHO-R,...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today reported its financial...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced the voting...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS

Patient recruitment for our Rotator cuff repair Phase I/II trial reached important milestone ORTHO-R soft-tissue residency properties confirmed in...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)
CHITOGENX RETAINS BRUDER CONSULTING & VENTURE GROUP TO BROADEN AND ACCELERATE ONGOING STRATEGIC DEVELOPMENT PARTNERSHIP DISCUSSIONS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced it has...

CHGX.CN : 0.0400 (-11.11%)
CHNXF : 0.0354 (-29.20%)

Business Summary

Chitogenx Inc. is a clinical-stage regenerative medicine company. It focuses on the development of novel therapeutic tissue repair technologies to improve tissue healing. Chitogenx Inc., formerly known as Ortho Regenerative Technologies Inc., is based in Canada.

See More

Key Turning Points

3rd Resistance Point 0.0431
2nd Resistance Point 0.0415
1st Resistance Point 0.0385
Last Price 0.0354
1st Support Level 0.0339
2nd Support Level 0.0323
3rd Support Level 0.0293

See More

52-Week High 0.1260
Fibonacci 61.8% 0.0912
Fibonacci 50% 0.0805
Fibonacci 38.2% 0.0698
Last Price 0.0354
52-Week Low 0.0350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar